Schedule 13G ownership disclosure

PTC Therapeutics Inc

Security class unavailable · CUSIP: 69366J200

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,645,701
Percent of class
2.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-20-000178
Form type
SC 13G
Filer
PTC THERAPEUTICS, INC.
CIK
CIK 1070081
Filed
Feb 14, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub